ArticleJournal of Cancer2017

MAP2K1 Mutation in Colorectal Cancer Patients: Therapeutic Challenge Using Patient-Derived Tumor Cell Lines.

J E Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.